Diagnosing rare diseases remains a critical challenge in clinical practice, often requiring specialist expertise. Despite the promising potential of machine learning, the scarcity of data on rare ...

obtaining performance comparable to senior ophthalmologists in a large cohort of Asian patients with choroid neoplasms.

Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...

Pharmaceutical activation of TREM2 (triggering receptor expressed on myeloid cells 2) suppressed laser-induced choroidal neovascularization, a model of wet age-related macular degeneration. Activation ...

Aura Biosciences (AURA) has reported its Q4 and full-year 2024 financial results, prompting an ongoing decline in shares despite showing ...

Uveal melanoma, which primarily affects Caucasian patients, is the most common primary intraocular tumor in adults2 that most ...

Early-stage choroidal melanoma represents an area of ... strategy to enroll approximately 100 patients with documented tumor growth. The CoMpass trial is actively enrolling globally.

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

14 With reported prevalence rates from 0.2% to 30% in the white population, clinicians regularly face the challenge of differentiating common choroidal naevus from the much less common but potentially ...